Literature DB >> 20972348

Association between centralization, depression, somatization, and disability among patients with nonspecific low back pain.

Susan L Edmond1, Mark W Werneke, Dennis L Hart.   

Abstract

STUDY
DESIGN: Secondary analysis of a prospective observational cohort study.
OBJECTIVES: To evaluate whether depression and somatization subscores of the Symptom Checklist-90-Revised (SCL-90-R), which have been shown to identify chronic disability in individuals with nonspecific low back pain, are applicable to a different population of individuals with low back pain; and to determine if this potential association is confounded by a combination of centralization and subsequent treatment based on centralization.
BACKGROUND: To help direct management of patients with nonspecific low back pain, recommendations include performing tests designed to identify psychosocial risk factors predictive of poor patient outcomes. SCL-90-R depression and somatization subscores have been shown to predict chronic disability among patients with low back pain.
METHODS: SCL-90-R depression and somatization subscores and data on centralization were collected during the initial physical therapy examination of 231 consecutive patients treated for low back pain in 2 clinics. Disability was assessed by the Oswestry Disability Questionnaire at intake and discharge from physical therapy, and work status was determined by patient self-report at 6 and 12 months after discharge. Pain intensity was assessed by the numeric pain rating scale at the initial visit, and at 6- and 12-month follow-ups. Data were analyzed using logistic regression.
RESULTS: Odds ratios for the association between depression and somatization subscores and patient outcomes ranged from 0.76 to 2.93. For analyses in which the data suggested a trend toward an association, the association was less evident following adjustment for centralization and centralization-based treatment.
CONCLUSIONS: In our sample, in which all individuals received physical therapy, and those who centralized received interventions based on the direction of centralization, SCL-90-R depression and somatization subscores were moderately associated with chronic pain and disability. This association was reduced when centralization and centralization-based treatment was considered in multivariable analyses.

Entities:  

Mesh:

Year:  2010        PMID: 20972348     DOI: 10.2519/jospt.2010.3334

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  6 in total

1.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

2.  Associations between low back pain and depression and somatization in a Canadian emerging adult population.

Authors:  David Robertson; Dinesh Kumbhare; Paul Nolet; John Srbely; Genevieve Newton
Journal:  J Can Chiropr Assoc       Date:  2017-08

3.  EVALUATION AND TREATMENT OF A PATIENT DIAGNOSED WITH ADHESIVE CAPSULITIS CLASSIFIED AS A DERANGEMENT USING THE MCKENZIE METHOD: A CASE REPORT.

Authors:  Ashley Bowser; Brian T Swanson
Journal:  Int J Sports Phys Ther       Date:  2016-08

4.  Physiotherapy assessment and treatment of chronic subjective tinnitus using mechanical diagnosis and therapy: a case report.

Authors:  Di Wu; David Ham; Richard Rosedale
Journal:  J Man Manip Ther       Date:  2020-01-16

5.  Mental Health of the Prison Medical Workers (PMWs) and Influencing Factors in Jiangxi, China.

Authors:  Xiaojun Liu; Dongdong Jiang; Zhaoxun Hou; Meikun He; Yuanan Lu; Zongfu Mao
Journal:  Int J Environ Res Public Health       Date:  2017-11-26       Impact factor: 3.390

6.  Comprehensiveness and validity of a multidimensional assessment in patients with chronic low back pain: a prospective cohort study.

Authors:  Thomas Benz; Susanne Lehmann; Achim Elfering; Peter S Sandor; Felix Angst
Journal:  BMC Musculoskelet Disord       Date:  2021-03-20       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.